Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Gwenn Waerlop

Faculty of Medicine and Health Sciences > Department of Diagnostic Sciences

ORCID iD: 0000-0003-3712-2979

Add to list
- Journal Article
- A1
- open access
Evaluation of safety, immunogenicity and cross-reactive immunity of OVX836, a nucleoprotein-based universal influenza vaccine, in older adults

Bart Jacobs, Isabel Leroux-Roels (UGent) , Jacques Bruhwyler, Nicola Groth, Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Azhar Alhatemi (UGent) , Philippe Moris, et al.

(2024) VACCINES. 12(12).
Add to list
- Journal Article
- A1
- open access
Safety and immunogenicity of a carbohydrate fatty acid monosulphate ester adjuvant combined with a low-dose quadrivalent split-virion inactivated influenza vaccine : a randomised, observer-blind, active-controlled, first-in-human, phase 1 study

Valentino D'Onofrio (UGent) , Sharon Porrez (UGent) , Bart Jacobs (UGent) , Azhar Alhatemi (UGent) , Fien De Boever (UGent) , Gwenn Waerlop (UGent) , Els Michels, Francesca Vanni, Alessandro Manenti, Geert Leroux-Roels (UGent) , et al.

(2024) VACCINES. 12(9).
Add to list
- Journal Article
- A1
- open access
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults : a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial

Isabel Leroux-Roels (UGent) , Chittappen Kandiyil Prajeeth, Amare Aregay, Niranjana Nair, Guus F Rimmelzwaan, Albert D M E Osterhaus, Simone Kardinahl, Sabrina Pelz, Stephan Bauer, Valentino D'Onofrio (UGent) , et al.

(2024) LANCET INFECTIOUS DISEASES. 24(11). p.1245-1253
Add to list
- PhD Thesis
- open access
Harmonization of cellular immunoassays for the evaluation of influenza vaccine immunogenicity

Gwenn Waerlop (UGent)

(2023)
Add to list
- Journal Article
- A1
- open access
Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant

Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Bart Jacobs (UGent) , Franziska Jarczowski, André Diessner, Geert Leroux-Roels (UGent) , Victor Klimyuk, Isabel Leroux-Roels (UGent) and Frank Thieme

(2023) FRONTIERS IN IMMUNOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial

Isabel Leroux-Roels (UGent) , Paul Willems, Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Jacques Bruhwyler, Azhar Alhatemi (UGent) , Bart Jacobs (UGent) , Florence Nicolas, et al.

(2023) LANCET INFECTIOUS DISEASES. 23(12). p.1360-1369
Add to list
- Journal Article
- A1
- open access
Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium

Sarah Begue, Gwenn Waerlop (UGent) , Bruno Salaun, Michel Janssens, Duncan Bellamy, Rebecca Jane Cox, Richard Davies, Elena Gianchecchi, Donata Medaglini, Emanuele Montomoli, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine

Isabel Leroux-Roels (UGent) , Cathy Maes, Jasper Joye, Bart Jacobs (UGent) , Franziska Jarczowski, André Diessner, Yorick Janssens (UGent) , Gwenn Waerlop (UGent) , Kirsi Tamminen, Suvi Heinimäki, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium

Gwenn Waerlop (UGent) , Geert Leroux-Roels (UGent) , Teresa Lambe, Duncan Bellamy, Donata Medaglini, Elena Pettini, Rebecca Jane Cox, Mai-Chi Trieu, Richard Davies, Geir Bredholt, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
The role of cell-mediated immunity against influenza and its implications for vaccine evaluation

Yorick Janssens (UGent) , Jasper Joye, Gwenn Waerlop (UGent) , Frédéric Clement (UGent) , Geert Leroux-Roels (UGent) and Isabel Leroux-Roels (UGent)

(2022) FRONTIERS IN IMMUNOLOGY. 13.

1
2

Next →